1. Home
  2. COCP vs AIRE Comparison

COCP vs AIRE Comparison

Compare COCP & AIRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cocrystal Pharma Inc.

COCP

Cocrystal Pharma Inc.

HOLD

Current Price

$1.07

Market Cap

14.1M

Sector

Health Care

ML Signal

HOLD

Logo reAlpha Tech Corp.

AIRE

reAlpha Tech Corp.

HOLD

Current Price

$1.44

Market Cap

11.5M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
COCP
AIRE
Founded
2006
2021
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.1M
11.5M
IPO Year
2011
2023

Fundamental Metrics

Financial Performance
Metric
COCP
AIRE
Price
$1.07
$1.44
Analyst Decision
Strong Buy
Buy
Analyst Count
1
3
Target Price
$6.00
$1.30
AVG Volume (30 Days)
44.4K
59.7K
Earning Date
05-15-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
54.65
60.34
EPS
N/A
N/A
Revenue
$12,712,091.00
$4,518,498.00
Revenue This Year
N/A
$129.06
Revenue Next Year
N/A
$83.72
P/E Ratio
N/A
N/A
Revenue Growth
N/A
376.42
52 Week Low
$0.76
$0.16
52 Week High
$2.03
$3.98

Technical Indicators

Market Signals
Indicator
COCP
AIRE
Relative Strength Index (RSI) 58.44 43.92
Support Level $0.99 $0.29
Resistance Level $1.11 $1.64
Average True Range (ATR) 0.06 0.15
MACD 0.02 0.03
Stochastic Oscillator 93.14 46.15

Price Performance

Historical Comparison
COCP
AIRE

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI). The company has one reportable and operating segment dedicated to the research and development company's novel orally administered antiviral influenza candidate. The company has pipeline products for diseases like : Influenza, Norovirus, Coronavirus, Respiratory Viruses, and Hepatitis C.

About AIRE reAlpha Tech Corp.

ReAlpha Tech Corp is a real estate technology company. The group is engaged in an end-to-end commission-free homebuying platform. It develops and utilizes its artificial intelligence-focused technology stack to empower retail investor participation in short-term rental properties, which are real estate units listed for a rental term. It provides short-term rental investment opportunities to everyday investors. The company has developed technologies and tools that allow for the analysis of short-term rental properties using AI to provide insight into that property's potential profitability and ways to increase such profitability. The company's reportable segments are Homebuying Services and the Technology Services segment.

Share on Social Networks: